Risk Factors for Severe Respiratory Syncytial Virus Infection in Elderly Persons

Journal of Infectious Diseases

Volumn 189, Issue 2, 2004, Pages 233-238

  Walsh, Edward E ^a,b,c   Peterson, Derick R ^a   Falsey, Ann R ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

AGED; AGING; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SEROLOGY; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 0742307345     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/380907     Document Type: Article

References (20)

1. Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to Chimpanzee Coryza Agent (CCA). Am J Hyg 1957; 66:281-90.
2. Mufson MA, Levine HD, Wasil RE, Mocega-Gonzalez HE, Krause HE. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol 1973; 98:88-95.
3. Brandt CD, Kim HW, Arrobio JO, Jeffries BC, Wood SC, Chanock R, Parrott RH. Epidemiology of respiratory syncytial virus infection in Washington, D.C. Am J Epidemiol 1973; 98:355-64.
4. Henderson FW, Collier AM, Clyde WA, Denny FW. Respiratory syncytial-virus infections, reinfections and immunity. N Engl J Med 1979; 300:530-4.
5. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163:693-8.
6. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371-84.
7. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial virus and other infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 1999; 160:791-5.
8. Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis 1998; 177:463-6.
9. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185:914-9.
10. Lawton PM. The function assessment of elderly people. J Am Geriatr Soc 1971; 19:465-81.
11. Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172:389-94.
12. Falsey AR, Formica MA, Walsh EE. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol 2002; 40:817-20.
13. Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 2003; 41:4160-5.
14. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358:1410-6.
15. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. Vaccine 1996; 14:1214-8.
16. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics - implications for prevention. Arch Intern Med 1982; 142:85-9.
17. Hall CB. Parainfluenza viruses. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. Philadelphia: W. B. Saunders, 1992:1613-25.
18. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchioloitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440-6.
19. Groothuis JR, Simoes EAF, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329:1524-30.
20. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997; 99:93-9.